SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000903423-16-001151
Filing Date
2016-07-13
Accepted
2016-07-13 17:23:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 arbutus13d.htm SC 13D 219783
  Complete submission text file 0000903423-16-001151.txt   221399
Mailing Address 55 RAILROAD AVENUE GREENWICH CT 06830
Business Address 55 RAILROAD AVENUE GREENWICH CT 06830 203-863-5062
VIKING GLOBAL INVESTORS LP (Filed by) CIK: 0001103804 (see all company filings)

IRS No.: 134055118 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Subject) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-85963 | Film No.: 161766185
SIC: 2834 Pharmaceutical Preparations